181 related articles for article (PubMed ID: 36033473)
1. Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China.
Zhou S; Tang J; Liang J; Lou Z; Fu W; Feng B; Yang Y; Xiao Y; Liu Q
Front Oncol; 2022; 12():916285. PubMed ID: 36033473
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.
Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
BMC Cancer; 2022 Feb; 22(1):136. PubMed ID: 35109810
[TBL] [Abstract][Full Text] [Related]
3. Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis.
Zhou S; Jiang Y; Liang J; Liu Q
World J Surg Oncol; 2022 Mar; 20(1):97. PubMed ID: 35351137
[TBL] [Abstract][Full Text] [Related]
4. Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China.
Xie Z; Chen Q; Feng B; Jiang Y; Wang X; Xing W; Liu Q;
BMC Cancer; 2024 Jan; 24(1):115. PubMed ID: 38263067
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis.
Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
BMC Surg; 2021 Dec; 21(1):441. PubMed ID: 34961494
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and safety of lateral pelvic lymph node dissection for elderly patients with middle-low rectal cancer: results of a large multicenter lateral node collaborative group study in China.
Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q
Tech Coloproctol; 2023 Aug; 27(8):655-664. PubMed ID: 36515808
[TBL] [Abstract][Full Text] [Related]
7. Distant Metastasis is the Dominant Cause of Treatment Failure after Lateral Lymph Node Dissection in Patients with Lateral Lymph Node Metastasis: Results of the Large Multicenter Lateral Node Study in China.
Li K; Wang F; Jiang Y; Hong G; Li Z; Liang J; Wu W; Xing W; Liu Q
J Cancer; 2023; 14(17):3227-3237. PubMed ID: 37928432
[No Abstract] [Full Text] [Related]
8. Prognostic Impact of Lateral Pelvic Node Dissection on the Survival of Patients in Low Rectal Cancer Subgroups Based on Lymph Node Size.
Hida K; Nishizaki D; Sumii A; Okamura R; Sakai Y; Konishi T; Akagi T; Yamaguchi T; Akiyoshi T; Fukuda M; Yamamoto S; Arizono S; Uemura M; Hasegawa H; Kawada K; Morita S; Watanabe M;
Ann Surg Oncol; 2021 Oct; 28(11):6179-6188. PubMed ID: 34255243
[TBL] [Abstract][Full Text] [Related]
9. Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis.
Ishihara S; Kanemitsu Y; Murono K; Otani K; Yasuda K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Sugihara K; Watanabe T
Int J Colorectal Dis; 2016 Jul; 31(7):1315-21. PubMed ID: 27240821
[TBL] [Abstract][Full Text] [Related]
10. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
[No Abstract] [Full Text] [Related]
11. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and prognostic significance of postoperative complications following lateral pelvic lymph node dissection for rectal cancer: results of the multicenter lateral node study in China.
Zhou S; Tang J; Mei S; Lou Z; Fu W; Feng B; Yang Y; Sun Y; Liu Q;
Jpn J Clin Oncol; 2022 Oct; 52(10):1150-1158. PubMed ID: 35858237
[TBL] [Abstract][Full Text] [Related]
13. Optimization of treatment strategies based on preoperative imaging features and local recurrence areas for locally advanced lower rectal cancer after lateral pelvic lymph node dissection.
Xu Z; Bao M; Cai Q; Wang Q; Xing W; Liu Q
Front Oncol; 2023; 13():1272808. PubMed ID: 38375201
[TBL] [Abstract][Full Text] [Related]
14. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
[TBL] [Abstract][Full Text] [Related]
15. Robotic and laparoscopic salvage lateral pelvic node dissection for the treatment of recurrent rectal cancer.
Kim HJ; Choi GS; Joshi H; Cho SH; Park JS; Park SY; Song SH; Kang MK
Surg Endosc; 2023 Jun; 37(6):4954-4961. PubMed ID: 37016084
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle-low rectal cancer: Results of a multicentre lateral node study in China.
Tang J; Zhou S; Zhao W; Lou Z; Liang J; Feng B; Yang Y; Wang X; Liu Q;
Colorectal Dis; 2022 Nov; 24(11):1325-1334. PubMed ID: 35713974
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Selective Lateral Node Dissection Based on Magnetic Resonance Imaging in Rectal Cancer After Preoperative Chemoradiotherapy.
Park BK; Lee SJ; Hur BY; Kim MJ; Chan Park S; Chang HJ; Kim DY; Oh JH
J Surg Res; 2018 Dec; 232():227-233. PubMed ID: 30463722
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of the number of lateral pelvic lymph node metastases on rectal cancer.
Ozawa H; Nakanishi H; Sakamoto J; Suzuki Y; Fujita S
Jpn J Clin Oncol; 2020 Oct; 50(11):1254-1260. PubMed ID: 32687179
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcomes of total mesorectal excision and selective lateral pelvic lymph node dissection for advanced low rectal cancer: a comparative study of a robotic versus laparoscopic approach.
Song SH; Choi GS; Kim HJ; Park JS; Park SY; Lee SM; Choi JA; Seok HA
Tech Coloproctol; 2021 Apr; 25(4):413-423. PubMed ID: 33594627
[TBL] [Abstract][Full Text] [Related]
20. Preliminary experience with lateral pelvic lymph node dissection in locally advanced rectal cancer.
Sinukumar S; Engineer R; Saklani A
Indian J Gastroenterol; 2015 Jul; 34(4):320-4. PubMed ID: 26334237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
